SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-10-033615
Filing Date
2010-06-16
Accepted
2010-06-15 17:31:11
Documents
6
Period of Report
2010-06-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v188346_8k.htm 8-K 33438
2 v188346_ex99-1.htm EX-99.1 25173
3 GRAPHIC chart1.jpg GRAPHIC 11630
4 GRAPHIC chart2.jpg GRAPHIC 12517
5 GRAPHIC logo.jpg GRAPHIC 3048
6 v188346_ex99-2.htm EX-99.2 36193
  Complete submission text file 0001144204-10-033615.txt   134284
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 10898987
SIC: 2836 Biological Products, (No Diagnostic Substances)